| P2093 | author name string | Chrousos GP | |
| P2860 | cites work | Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats | Q69840216 |
| | Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling | Q70076991 |
| | Corticotropin-releasing activity of monokines | Q70107751 |
| | Ovine corticotropin-releasing hormone stimulation test in normal children | Q70118878 |
| | Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study | Q70119071 |
| | The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome | Q70152825 |
| | The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man | Q70157833 |
| | Effect of adrenaline on basal and ovine corticotrophin-releasing factor-stimulated ACTH secretion in man | Q70166663 |
| | Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training | Q70176653 |
| | Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man | Q70185539 |
| | The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency | Q70213759 |
| | Haemodynamic and neuroendocrine consequences of stopping smoking--a controlled study | Q70407619 |
| | Urinary adrenaline concentrations during 10 days of smoking abstinence | Q70503743 |
| | Human Corticotropin-Releasing Factor in Man: Pharmacokinetic Properties and Dose-Response of Plasma Adrenocorticotropin and Cortisol Secretion | Q72397937 |
| | In Vivo Corticotropin-Releasing Factor-Induced Secretion of Adrenocorticotropin, β-Endorphin, and Corticosterone* | Q72917576 |
| | Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins | Q24311515 |
| | Isolation of the human plasma corticotrophin-releasing factor-binding protein | Q28253694 |
| | Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 |
| | Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta | Q33632962 |
| | Stress-induced alterations of immunity in hypophysectomized rats | Q33682521 |
| | Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats | Q33847787 |
| | A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats | Q33864605 |
| | Structural analysis of the regulatory region of the human corticotropin releasing hormone gene | Q34343352 |
| | The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis | Q34350872 |
| | Adrenocorticotropin and Cortisol Responses to Vasopressin during Pregnancy* | Q34497378 |
| | Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome | Q34510653 |
| | Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications | Q34555737 |
| | Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro | Q34561818 |
| | NIH conference. Clinical applications of corticotropin-releasing factor | Q34563967 |
| | Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications | Q34629308 |
| | Cloning and sequence analysis of cDNA for ovine corticotropin-releasing factor precursor | Q34711642 |
| | Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action | Q36297944 |
| | Characterization of rat hypothalamic corticotropin-releasing factor | Q37345089 |
| | Corticosterone levels determine individual vulnerability to amphetamine self-administration | Q37426195 |
| | Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. | Q41199345 |
| | Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth | Q41270381 |
| | The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism | Q41272595 |
| | The rat corticotropin-releasing hormone gene | Q41334359 |
| | Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist | Q41335474 |
| | Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro | Q41346745 |
| | Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. | Q41364625 |
| | Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy | Q41371227 |
| | The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome | Q41448417 |
| | Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. | Q41710815 |
| | Glucocorticoid Repression of 3',5'-Cyclic-Adenosine Monophosphate-Dependent Human Corticotropin-Releasing-Hormone Gene Promoter Activity in a Transfected Mouse Anterior Pituitary Cell Line | Q41724317 |
| | Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages | Q41729387 |
| | Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern | Q41972854 |
| | The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome | Q42453785 |
| | Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study | Q42459669 |
| | Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery | Q42462298 |
| | Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome | Q42462984 |
| | In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications | Q42479735 |
| | Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications | Q42508360 |
| | Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats | Q42599463 |
| | Low urinary cortisol excretion in patients with posttraumatic stress disorder. | Q43527223 |
| | Corticotropin-Releasing Hormone Is not the Sole Factor Mediating Exercise-Induced Adrenocorticotropin Release in Humans* | Q43703319 |
| | Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor | Q43956860 |
| | The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency | Q44644951 |
| | The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat. | Q44654819 |
| | Spontaneous and Glucocorticoid-Inhibited Adrenocorticotropic Hormone and Cortisol Secretion are Similar in Healthy Young and Old Men* | Q44690206 |
| | Interaction of epidermal growth factor with the hypothalamic-pituitary-adrenal axis: potential physiologic relevance | Q44953012 |
| | Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics | Q45283862 |
| | Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene | Q46198935 |
| | Spontaneous and stimulated adrenocorticotropin and vasopressin pulsatile secretion in the pituitary venous effluent of the horse | Q46245482 |
| | Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. | Q46285979 |
| | Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor | Q46409186 |
| | Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hor | Q46789668 |
| | Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients | Q47208531 |
| | Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function | Q48187416 |
| | Nucleotide sequence of the gene coding for ovine corticotropin-releasing factor and regulation of its mRNA levels by glucocorticoids. | Q48310485 |
| | Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system | Q48386283 |
| | Pituitary-adrenal responsiveness to corticotropin-releasing hormone in patients receiving chronic, alternate day glucocorticoid therapy | Q48477264 |
| | Corticotropin releasing factor-like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: colocalization with other neuropeptides | Q48516183 |
| | Studies of the Nature of the Interaction between Vasopressin and Corticotropin-Releasing Factor on Adrenocorticotropin Release in the Rat* | Q48632531 |
| | Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells | Q48752837 |
| | Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat. | Q48765158 |
| | Evidence for acute ACTH release by extrahypothalmic mechanisms | Q48771950 |
| | Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study | Q48788992 |
| | Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome | Q48869877 |
| | Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone | Q48890200 |
| | Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin | Q48895608 |
| | Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. | Q48961740 |
| | Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity | Q48961758 |
| | The hypothalamic-pituitary-adrenal axis in infantile malnutrition | Q49044931 |
| | Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. | Q49068345 |
| | Induction of beta-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor | Q49124139 |
| | Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. | Q51201974 |
| | Withdrawal syndrome with gradual tapering of alprazolam. | Q51206728 |
| | Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. | Q51765982 |
| | Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. | Q51767655 |
| | Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. | Q51791641 |
| | Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications | Q52051754 |
| | Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. | Q52062453 |
| | Positive Feedback of Vasopressin on its Own Release in the Central Nervous System: in vitro Studies. | Q52106546 |
| | Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. | Q52235332 |
| | Effect of hypertonic saline infusion on the level of immunoreactive dynorphin in extracted human plasma. | Q52240686 |
| | Arachidonic acid metabolites modulate rat hypothalamic corticotropin-releasing hormone secretion in vitro. | Q52244144 |
| | The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease. | Q52245929 |
| | Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. | Q52248002 |
| | Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides. | Q52251939 |
| | Urinary Free-Cortisol Levels in Posttraumatic Stress Disorder Patients | Q57311804 |
| | Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins | Q59081573 |
| | Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. | Q64975983 |
| | Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression | Q68122111 |
| | Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? | Q68166537 |
| | Rat hypothalamic corticotropin-releasing hormone secretion in vitro is stimulated by interleukin-1 in an eicosanoid-dependent manner | Q68367814 |
| | The corticotrophin releasing hormone test in late pregnancy: lack of adrenocorticotrophin and cortisol response | Q68477762 |
| | Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia | Q69345614 |
| | Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse | Q69364391 |
| | Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception | Q69440074 |
| | Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression | Q69742012 |
| | Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease | Q69829052 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 833-858 | |
| P577 | publication date | 1992-12-01 | |
| P1433 | published in | Endocrinology and Metabolism Clinics of North America | Q15763298 |
| P1476 | title | Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective | |
| P478 | volume | 21 | |